Mukka Proteins Q2 FY27: revenue up 108.1% to ₹509 Cr, net profit up 156.5% to ₹18 Cr
Results · Finvezto · 7 Nov 2026 · Mukka Proteins (MUKKA)
Results Q2 FY27, ₹ Cr
| Q2 FY27 | ₹ Cr | QoQ | YoY |
|---|---|---|---|
| Revenue | 509 | +3.9% | +108.1% |
| Operating profit | 42 | -11.9% | +104.3% |
| Net profit | 18 | -4.8% | +156.5% |
| Operating margin | 8.3% | -1.5 pp | -0.2 pp |
| Net margin | 3.5% | -0.3 pp | +0.7 pp |
Key points
- Mukka Proteins Limited reported a consolidated revenue of Rs 508.87 crore for Q2 FY27, up 108.06% year-on-year from Rs 244.58 crore, with EBITDA rising 90.73% to Rs 50.12 crore and net profit increasing 157.51% to Rs 17.73 crore. NSE filing
- Commercial production commenced at the Al Juba facility in Oman, expanding total manufacturing capacity to 340,170 MTPA alongside securing US FDA facility registration. NSE filing
- Revenue was ₹509 Cr, up 108.1% on a year earlier and up 3.9% on the quarter before. Finvezto data
What to watch
- Operating margin over the last 4 quarters (Dec 25, Mar 26, Jun 26, Sep 26): 6.9%, 8.9%, 9.8%, 8.3%.
- Net profit over the last 4 quarters (Dec 25, Mar 26, Jun 26, Sep 26), ₹ Cr: 27, 21, 19, 18.
Links
NSE filing (PDF) · Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.